Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
16454-1 Beta galactosidase CCnc Bld Pt Qn     ACTIVE Beta galactosidase [Enzymatic activity/volume] in Blood   MIN DefinitionDescription     umol/h/L             CHEM   16454-1         Both       0 B-Galactosidase Bld-cCnc       Y   B; B-Galactosidase; Blood; Catalytic Concentration; Chemistry; Disaccharidase; GM 1-gangliosidosis; Lactase; Morquio disease type B; MPS IV B; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.73 1.0l               umol/h/L       0
16455-8 Beta hydroxybutyrate SCnc CSF Pt Qn     ACTIVE Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid   MIN DefinitionDescription     mmol/L             CHEM   16455-8         Both       0 B-OH-Butyr CSF-sCnc       Y   3-hydroxybutyrate; 3-hydroxybutyric acid; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; BOHB; B-OH-Butyr; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hydroxybutyric acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration 2.34 1.0l               mmol/L       0
16456-6 Beta hydroxybutyrate SCnc Urine Pt Qn     ACTIVE Beta hydroxybutyrate [Moles/volume] in Urine   MIN DefinitionDescription     mmol/L             CHEM   16456-6         Both       0 B-OH-Butyr Ur-sCnc       Y   3-hydroxybutyrate; 3-hydroxybutyric acid; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; BOHB; B-OH-Butyr; Chemistry; Hydroxybutyric acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.73 1.0l               mmol/L       0
16457-4 Beta-N-acetylhexosaminidase.A CCnc WBC Pt Qn     ACTIVE Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes   MIN DefinitionDescription                   CHEM   16457-4         Both       0 Hexosaminidase A WBC-cCnc       Y   B; Beta-hexosaminidase subunit alpha; B-NAH; Catalytic Concentration; Chemistry; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase A; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; Tay Sachs Disease; WBCs; White blood cells 2.73 1.0l               nmol/mL/min       0
16458-2 Bethanechol MCnc Ser/Plas Pt Qn     ACTIVE Bethanechol [Mass/volume] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   16458-2         Both       0 Bethanechol SerPl-mCnc       Y   1-Propanaminium; C7H17ClN2O2; DRUG/TOXICOLOGY; Drugs; Duvoid; Level; Mass concentration; Myotonine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Urabeth; Urecholine 2.34 1.0l                       0
16459-0 Bicarbonate SCnc Body fld Pt Qn     ACTIVE Bicarbonate [Moles/volume] in Body fluid   MIN DefinitionDescription     mmol/L             CHEM   16459-0         Both       0 HCO3 Fld-sCnc       Y   B/F; BF; BIC; bicar; Bicarb; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; HCO3; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.34 1.0l               mmol/L       0
1646-9 Xylose^post dose PO MRat Urine 5H Qn     ACTIVE Xylose [Mass/time] in 5 hour Urine --post dose PO   MIN DefinitionDescription     g/5 H             CHAL   1646-9         Observation       0 Xylose p PO 5h Ur-mRate       Y   5 hours; 5.0Hr; 5HR; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Mass rate; mRate; p dose; p PO; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn; Xylose absorption test 2.73 1               g/(5.h)       0
16460-8 Bicarbonate SCnc CSF Pt Qn     ACTIVE Bicarbonate [Moles/volume] in Cerebral spinal fluid   MIN DefinitionDescription     mmol/L             CHEM   16460-8         Both       0 HCO3 CSF-sCnc       Y   BIC; bicar; Bicarb; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; HCO3; Level; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration 2.34 1.0l               mmol/L       0
16461-6 Bicarbonate SCnc RBC Pt Qn     ACTIVE Bicarbonate [Moles/volume] in Red Blood Cells   MIN DefinitionDescription     mmol/L             CHEM   16461-6         Both       0 HCO3 RBC-sCnc       Y   BIC; bicar; Bicarb; Chemistry; Erythrocytes; HCO3; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration 2.34 1.0l               mmol/L       0
16462-4 Bicarbonate SCnc Amnio fld Pt Qn     ACTIVE Bicarbonate [Moles/volume] in Amniotic fluid   MIN DefinitionDescription     mmol/L             CHEM   16462-4         Both       0 HCO3 Amn-sCnc       Y   AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; BIC; bicar; Bicarb; Chemistry; Gyn; Gynecology; HCO3; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.34 1.0l               mmol/L       0
16463-2 Bile acid.dihydroxy MCnc Ser/Plas Pt Qn     ACTIVE Bile acid.dihydroxy [Mass/volume] in Serum or Plasma   MAJ DefinitionDescription     ug/mL             CHEM   16463-2         Both       0 Di-OH Bile Ac SerPl-mCnc       Y   Acd; Acids; Bile acid.total; Bile salt; Chemistry; Di-OH Bile Ac; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.67 1.0l               ug/mL     Release 2.67: SYSTEM: Added Plas because this test can be run on both serum and plasma 0
16464-0 Bile acid ACnc Exhl gas Pt Qn     ACTIVE Bile acid [Units/volume] in Exhaled gas   MIN DefinitionDescription                   CHEM   16464-0         Both       0 Bile Ac ExG-aCnc       Y   Acd; Acids; Arbitrary concentration; Bile acid.total; Bile salt; Breath; Chemistry; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Point in time; QNT; Quan; Quant; Quantitative; Random 2.69 1.0l               [arb'U]/mL       0
16465-7 Bile acid MCnc Urine Pt Qn     ACTIVE Bile acid [Mass/volume] in Urine   MIN DefinitionDescription                   CHEM   16465-7         Both       0 Bile Ac Ur-mCnc       Y   Acd; Acids; Bile acid.total; Bile salt; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l                       0
16466-5 Bile acid.trihydroxy MCnc Ser/Plas Pt Qn     ACTIVE Bile acid.trihydroxy [Mass/volume] in Serum or Plasma   MAJ DefinitionDescription     ug/mL             CHEM   16466-5         Both       0 Tri-OH Bile Ac SerPl-mCnc       Y   Acd; Acids; Bile acid.total; Bile salt; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri OH; Tri-OH; Tri-OH Bile Ac 2.67 1.0l               ug/mL     Release 2.67: SYSTEM: Added Plas because this test can be run on both serum and plasma 0
16467-3 Bismuth PrThr Bld Pt Ord     ACTIVE Bismuth [Presence] in Blood   MIN DefinitionDescription                   DRUG/TOX   16467-3         Both       0 Bismuth Bld Ql           BI; Blood; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood 2.56 1.0l                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16468-1 Bismuth PrThr Urine Pt Ord     ACTIVE Bismuth [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   16468-1         Both       0 Bismuth Ur Ql           BI; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16469-9 Bismuth/Creatinine MRto Urine Pt Qn     ACTIVE Bismuth/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription     ug/g creatinine             DRUG/TOX   16469-9         Both       0 Bismuth/Creat Ur       Y   BI; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.73 1.0l               ug/g{creat}       0
1647-7 Tuberculosis reaction wheal^3D post 25 TU ID Diam Skin Pt Qn     ACTIVE Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal   MIN DefinitionDescription     mm             CHALSKIN   1647-7         Observation       0 TB Wheal 3D p 25 TU Diam       Y   2nd strength PPD; 3D p 25 TU; After; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; Point in time; PPD; PST; Purified protein derivative skin test; Purified protein derivative test; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rxn; Skin test; SKIN TESTS; Skn; TB; TB skin test; TB Wheal; TST; Tubeculin Units 2.26 1               mm       0
16470-7 Blastomyces dermatitidis Ab PrThr Ser Pt Ord Comp fix   ACTIVE Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation   MIN DefinitionDescription                   MICRO   16470-7   Comp fix     Both       0 B dermat Ab Ser Ql CF           ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B dermat; B dermatitidis; Blasto; Blastomycosis; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.73 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16471-5 Blastomyces dermatitidis Ab ACnc Ser Pt Qn     ACTIVE Blastomyces dermatitidis Ab [Units/volume] in Serum   MIN DefinitionDescription                   MICRO   16471-5         Both       0 B dermat Ab Ser-aCnc       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B dermat; B dermatitidis; Blasto; Blastomycosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.73 1.0l               [arb'U]/mL       0
16472-3 Blastomyces dermatitidis rRNA PrThr Ser Pt Ord Probe   ACTIVE Blastomyces dermatitidis rRNA [Presence] in Serum by Probe   MIN DefinitionDescription                   MICRO   16472-3   Probe     Both       0 B dermat rRNA Ser Ql Probe           B dermat; B dermatitidis; Blasto; Blastomycosis; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Serum; SR 2.63 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. In the Short Name 'Prb' was changed to 'Probe' for clarity. 0
16473-1 Bordetella parapertussis Ab ACnc Ser Pt Qn     ACTIVE Bordetella parapertussis Ab [Units/volume] in Serum   MIN DefinitionDescription                   MICRO   16473-1         Both       0 B parapert Ab Ser-aCnc       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B parapert; B parapertussis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Whooping cough 2.69 1.0l               [arb'U]/mL       0
16474-9 Bordetella pertussis Ab ACnc Ser Pt Qn Comp fix   ACTIVE Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation   MIN DefinitionDescription                   MICRO   16474-9   Comp fix     Both       0 B pert Ab Ser CF-aCnc       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B pert; B pertussis; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Pertussis; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Whooping cough 2.69 1.0l               [arb'U]/mL       0
16475-6 Borrelia burgdorferi Ab PrThr CSF Pt Ord IA   ACTIVE Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay   MIN DefinitionDescription                   MICRO   16475-6   IA     Both       0 B burgdor Ab CSF Ql IA           ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS 2.73 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
16476-4 Borrelia burgdorferi Ab PrThr Body fld Pt Ord IA   ACTIVE Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay   MIN DefinitionDescription                   MICRO   16476-4   IA     Both       0 B burgdor Ab Fld Ql IA           ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; B/F; Bb; BF; bod; Bodies; Body fluid; Body fluid, unsp; Burgdorf; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS 2.56 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found